drugset / Trial / NCT00068198

Human Immune Responses Smallpox

NCT00068198

Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to attempt to identify the immune response of healthy adults to an investigational dilution of the Dryvax smallpox vaccine. In addition, we will try to determine whether certain genetic characteristics influence the size of the sore around the vaccination site, and use blood samples from subjects in the study to make a new form of antibody that could be given to people with vaccine side effects.

Timeline

Start
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dryvax Vaccine

Indications